POLICY

Price disclosure legislation unlikely to lower drug costs

CLEMSON, South Carolina -- The Trump administration's proposal to require pharmaceutical companies to publish drug prices in TV ads is unlikely to help control drug prices, according to a study publishing Jan. 22, 2019, in JAMA Internal Medicine.

China Is Taking Over Leadership in Science

China is on its way to becoming the world leader in science and technology. China is moving fast in science and technology, and the United States may lose its place.

Cigarette Carcinogens Failure To Sustain Government Set Lowered Levels On Manufacturers, Study Show

The Canadian Government subsidies were used to help manufacturers lower the level of carcinogens in their tobacco products. The initial years from 2005 to 2007 saw the maintained levels of carcinogens but the succeeding years from 2007 to 2012 shot up to up to 40 times the figure of 2007 which indicated the failure to sustain the government set policy.Medical Xpress reports that the study published in the journal Nicotine and Tobacco Research that an initial 2-year success was seen but was unsustainable and even went higher two to 40 times higher than the 2007 values. Co-author and researcher at the School of Public Health and Health Systems at the University of Waterloo, Ontario, Dr. David Hammond says, that the increase in TSNA in the 90%of cigarettes sold in Canada is alarming.Dr. Hammond adds that although the TNSA increase is not a direct health risk, cigarette manufacturers should be responsible for minimizing the exposure of customers to the harmful level of potent carcinogens in their tobacco products. The Government with all the subsidies it gave to the makers of these brands should monitor the company's' commitments and ensure the levels are kept under the limits set.
26 27 28 29 30 31 32 33 34
Most Popular

Recommended Stories